ABC Arbitrage SA Invests $2.52 Million in Amedisys, Inc. (NASDAQ:AMED)

ABC Arbitrage SA bought a new stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 27,782 shares of the health services provider's stock, valued at approximately $2,522,000. ABC Arbitrage SA owned 0.08% of Amedisys as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Pacer Advisors Inc. raised its holdings in Amedisys by 11,621.9% in the fourth quarter. Pacer Advisors Inc. now owns 558,197 shares of the health services provider's stock worth $50,679,000 after purchasing an additional 553,435 shares during the period. Polar Asset Management Partners Inc. bought a new stake in Amedisys during the 3rd quarter worth about $28,953,000. Verition Fund Management LLC boosted its position in Amedisys by 608.1% during the third quarter. Verition Fund Management LLC now owns 114,774 shares of the health services provider's stock valued at $11,077,000 after purchasing an additional 98,565 shares during the last quarter. Westchester Capital Management LLC grew its stake in shares of Amedisys by 9.5% in the third quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider's stock valued at $107,976,000 after buying an additional 97,476 shares in the last quarter. Finally, Calamos Advisors LLC increased its stake in shares of Amedisys by 22.7% during the 4th quarter. Calamos Advisors LLC now owns 487,444 shares of the health services provider's stock worth $44,255,000 after purchasing an additional 90,097 shares during the last quarter. 94.36% of the stock is owned by institutional investors.

Amedisys Price Performance

Shares of NASDAQ AMED traded up $0.06 during midday trading on Wednesday, reaching $92.61. The company's stock had a trading volume of 504,886 shares, compared to its average volume of 271,134. The business's 50 day moving average price is $90.53 and its two-hundred day moving average price is $93.50. The company has a market cap of $3.03 billion, a P/E ratio of 36.75, a P/E/G ratio of 1.83 and a beta of 0.73. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. Amedisys, Inc. has a fifty-two week low of $82.15 and a fifty-two week high of $98.95.

Wall Street Analyst Weigh In

Separately, Stephens reiterated an "equal weight" rating and issued a $101.00 price objective on shares of Amedisys in a report on Wednesday, February 12th. Five research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, Amedisys has a consensus rating of "Hold" and a consensus target price of $100.75.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.